The Minnesota Department of Health (MDH) has identified a second meningitis case in a patient treated with injectable steroids from a compounding pharmacy in Massachusetts.

Like the first case, the new case involves a woman in her forties who was evaluated after having possible symptoms of meningitis. Like the first patient, she was hospitalized, and is being treated with antibiotic and antifungal drugs.

MDH officials believe they may see additional cases as they proceed with the task of notifying approximately 950 Minnesota patients who were treated with steroid products produced by the New England Compounding Center. Additional cases will not be proactively announced, but will be posted to the MDH website at http://www.health.state.mn.us/divs/idepc/diseases/meningitis/fungal/index.html.

The site where the case numbers are posted includes a subscription option, so users can receive regular email updates whenever new information becomes available.